NexgenRx Announces Contract Changes
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 04/11/13 -- NEXGENRX INC. (TSX VENTURE: NXG) ("NexgenRx" or the "Corporation") announces that it has received notice from one of its clients, Accertaclaim Servicorp Inc., that they will not be renewing their contract with the Corporation on September 1, 2013.
Accerta, a client of the Corporation since November 2006, have taken the strategic decision to exit the private TPA market and focus on the public welfare dental business by purchasing their own dental claims system and operating it in-house. It should be noted that Accerta has confirmed that this decision is not a result of any issues with service, performance, pricing or reliability of NexgenRx's products or services.
"We appreciate the strategic decision Accerta has taken to return to their core dental business and our current analysis indicates that the impact to our net income for 2013 will be approximately $100,000 (+/- 10%). Notwithstanding this change, we are confident that with our recently introduced sales strategy and our pipeline of prospective clients, we will continue the positive trajectory for our business" stated Ron Loucks, President & CEO.
About NexgenRx
NexgenRx is Canada's leading independent health benefits plan administrator, providing proprietary on-line claims adjudication and web-based solutions to effectively manage benefits costs for plan sponsors and their members. More information on NexgenRx can be found at .
Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.
Contacts:
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801
NexgenRx Inc.
Taba Merrikh
Director of Finance
416.695.3393 x803
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.04.2013 - 02:53 Uhr
Sprache: Deutsch
News-ID 248464
Anzahl Zeichen: 0
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Insurance
Diese Pressemitteilung wurde bisher 251 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NexgenRx Announces Contract Changes"
steht unter der journalistisch-redaktionellen Verantwortung von
NexgenRx Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
